ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort

Neurology

Volumn 83, Issue 14, 2014, Pages 1271-1276

  Alexander, Kristine S ^a   Zakai, Neil A ^a,b   Gillett, Sarah ^a   McClure, Leslie A ^c   Wadley, Virginia ^c   Unverzagt, Fred ^d   Cushman, Mary ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (Canada)

^c University of Alabama at Birmingham   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD GROUP ABO SYSTEM;

ADULT; ARTICLE; BLOOD GROUP AB; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; CASE CONTROL STUDY; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; UNITED STATES; AFRICAN AMERICAN; BLOOD; BLOOD GAS ANALYSIS; CAUCASIAN; COGNITION DISORDERS; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST;

ABO BLOOD-GROUP SYSTEM; AFRICAN AMERICANS; BLOOD GAS ANALYSIS; CASE-CONTROL STUDIES; COGNITION DISORDERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR VIII; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84921718607     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000844     Document Type: Article

References (31)

1. Unverzagt FW, McClure LA, Wadley VG, et al. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology 2011; 77: 1729-1736.
2. Knopman DS, Mosley TH, Catellier DJ, Coker LH. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI Study. Alzheimers Dement 2009; 5: 207-214.
3. Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 2001; 56: 1683-1689.
4. Reijmer YD, van den Berg E, Dekker JM, et al. Development of vascular risk factors over 15 years in relation to cognition: The Hoorn Study. J Am Geriatr Soc 2012; 60: 1426-1433.
5. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005; 62: 1556-1560.
6. Gallacher J, Bayer A, Lowe G, et al. Is sticky blood bad for the brain? Hemostatic and inflammatory systems and dementia in the Caerphilly Prospective Study. Arterioscler Thromb Vasc Biol 2010; 30: 599-604.
7. HagneliusNO, Boman K, Nilsson TK. Fibrinolysis and von Willebrand factor in Alzheimer's disease and vascular dementia: A case-referent study. Thromb Res 2010; 126: 35-38.
8. Quinn TJ, Gallacher J, Deary IJ, Lowe GD, Fenton C, Stott DJ. Association between circulating hemostatic measures and dementia or cognitive impairment: Systematic review and meta-Analyzes. J Thromb Haemost 2011; 9: 1475-1482.
9. Stott DJ, Spilg E, Campbell AM, Rumley A, Mansoor MA, Lowe GD. Haemostasis in ischaemic stroke and vascular dementia. Blood Coagul Fibrinolysis 2001; 12: 651-657.
10. He M, Wolpin B, Rexrode K, et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012; 32: 2314-2320.
11. Wiggins KL, Smith NL, Glazer NL, et al. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost 2009; 7: 263-269.
12. Ohira T, Cushman M, Tsai MY, et al. ABO blood group, other risk factors and incidence of venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 2007; 5: 1455-1461.
13. Liumbruno GM, Franchini M. Beyond immunohaematology: The role of the ABO blood group in human diseases. Blood Transfus 2013; 11: 491-499.
14. Dentali F, Sironi AP, Ageno W, Crestani S, Franchini M. ABO blood group and vascular disease: An update. Semin Thromb Hemost 2014; 40: 49-59.
15. van Schie MC, van Loon JE, de Maat MP, Leebeek FW. Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: A review. J Thromb Haemost 2011; 9: 899-908.
16. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-155.
17. Bath PM, Anderton PR, Ankolekar S. Hemostasis and vascular dementia. Arterioscler Thromb Vasc Biol 2010; 30: 461-463.
18. Zakai NA, Judd SE, Alexander K, et al. ABO blood type and stroke risk: The Reasons for Geographic and Racial Differences in Stroke Study. J Thromb Haemost 2014; 12: 564-570.
19. Howard VJ, Cushman M, Pulley L, et al. The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and design. Neuroepidemiology 2005; 25: 135-143.
20. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194.
21. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246.
22. Thacker EL, Gillett SR, Wadley VG, et al. The American Heart Association Life's Simple 7 and incident cognitive impairment: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. J Am Heart Assoc 2014; 3: E000635.
23. Cushman M, Judd SE, Howard VJ, et al. N-Terminal pro-B-Type natriuretic peptide and stroke risk: The Reasons for Geographic and Racial Differences in Stroke Cohort. Stroke 2014; 45: 1646-1650.
24. Ranade K, Chang MS, Ting CT, et al. High-Throughput genotyping with single nucleotide polymorphisms. Genome Res 2001; 11: 1262-1268.
25. Fillit H, Nash DT, Rundek T, Zuckerman A. Cardiovascular risk factors and dementia. Am J Geriatr Pharmacother 2008; 6: 100-118.
26. Ganguli M, Fu B, Snitz BE, Hughes TF, Chang CC. Mild cognitive impairment: Incidence and vascular risk factors in a population-based cohort. Neurology 2013; 80: 2112-2120.
27. Ewers M, Mielke MM, Hampel H. Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Exp Gerontol 2010; 45: 75-79.
28. Hochstrasser T, Weiss E, Marksteiner J, Humpel C. Soluble cell adhesion molecules in monocytes of Alzheimer's disease and mild cognitive impairment. Exp Gerontol 2010; 45: 70-74.
29. Jaremo P, Milovanovic M, Buller C, Nilsson S, Winblad B. P-selectin paradox and dementia of the Alzheimer type: Circulating P-selectin is increased but platelet-bound P-selectin after agonist provocation is compromised. Scand J Clin Lab Invest 2013; 73: 170-174.
30. Anstee DJ. The relationship between blood groups and disease. Blood 2010; 115: 4635-4643.
31. Kaufman RJ, Dorner AJ, Fass DN. von Willebrand factor elevates plasma factor VIII without induction of factor VIII messenger RNA in the liver. Blood 1999; 93: 193-197.